Please assess the completion status of the following clinical trial:

Trial Title: Fluorescence Targeted Pelvic Lymph Node Mapping

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participant is willing and able to give informed consent for participation in the study.~* Male or Female, aged 18 years or above.~* Participant is undergoing elective curative surgery for rectal adenocarcinoma~* Participant is willing and able to comply with study requirements~Exclusion Criteria:~* Participant has history of or known allergy to indocyanine green~* Participant has history of or known allergy to iodides~* Participant suffers from hyperthyroidism or has a benign thyroid tumour~* Participant has renal failure~* Female participant currently pregnant, planning pregnancy or breast feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Tumour injection of ICG (Type: EXPERIMENTAL): Indocyanine green injection into tumour before or during surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).